Neuronetics, Inc. Reports Q2 2026 Financial Results

What Happened

• Neuronetics, Inc. announced its financial results for the three and six months ended June 30, 2026 in a press release dated August 11, 2026. The company furnished that press release to the SEC as Exhibit 99.1 to the Form 8‑K.
• On the same date the company also released a presentation it may use with investors; that presentation is attached as Exhibit 99.2 and was disclosed under Regulation FD in the Form 8‑K.

Key Details

• Filing date: August 11, 2026 (Form 8‑K).
• Period covered: three and six months ended June 30, 2026.
• Exhibits included: 99.1 (Press Release), 99.2 (Company Presentation), and 104 (Inline XBRL cover page).
• Disclosure type: Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD presentation disclosure).

Why It Matters

• The press release and presentation contain the company’s most recent quarterly financial results and related commentary; investors should review those documents to see revenue, profit/loss, cash flow and any management discussion.
• The Regulation FD disclosure ensures the presentation materials were made available to investors and the market; timely review can help shareholders assess near-term performance and business trends.
• These filings do not themselves include additional corporate actions (e.g., executive changes or mergers); they primarily provide the company’s updated financial and investor presentation materials.